Prague Med. Rep. 2016, 117, 34-41

https://doi.org/10.14712/23362936.2016.3

Combination of Steroids and Azathioprine in the Treatment of Ormond’s Disease – A Single Centre Retrospective Analysis

Miroslav Průcha1, Ivan Kolombo2, Petr Štádler3

1Department of Clinical Biochemistry, Haematology and Immunology, Na Homolce Hospital, Prague, Czech Republic
2Department of Urology, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady, Prague, Czech Republic
3Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic

Received December 1, 2015
Accepted February 24, 2016

References

1. Binder, M., Uhl, M., Wiech, T., Kollert, F., Thiel, J., Sass, J. O., Walker, U. A., Peter, H. H., Warnatz, K. (2012) Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann. Rheum. Dis. 71, 311–312. <https://doi.org/10.1136/annrheumdis-2011-200148>
2. Brandt, A. S., Kamper, L., Kukuk, S., Haage, P., Roth, S. (2014) Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis. Urol. Int. 93, 320–325. <https://doi.org/10.1159/000357814>
3. Brito-Zerón, P., Ramos-Casals, M., Bosch, X., Stone, J. H. (2014) The clinical spectrum of IgG4 related disease. Autoimmun. Rev. 13, 1203–1210. <https://doi.org/10.1016/j.autrev.2014.08.013>
4. Cartery, C., Astudillo, L., Deelchand, A., Moskovitch, G., Sailler, L., Bossavy, J. P., Arlet, P. (2011) Abdominal infectious aortitis caused by Streptococcus pneumoniae: a case report and literature review. Ann. Vasc. Surg. 25, e9–e16. <https://doi.org/10.1016/j.avsg.2010.07.014>
5. Dagna, L., Salvo, F., Tiraboschi, M., Bozzolo, E. P., Franchini, S., Doglioni, C. A., Manfredi, A., Baldissera, E., Sabbadini, M. G. (2011) Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann. Intern. Med. 155, 425–433. <https://doi.org/10.7326/0003-4819-155-7-201110040-00005>
6. Ford, L. T., Berg, J. D. (2010) Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment, a pharmacogenomic test whose time has come. J. Clin. Pathol. 63, 288–295. <https://doi.org/10.1136/jcp.2009.069252>
7. Koo, Y. W., Hong, S., Kim, Y. J., Kim, Y. G., Lee, C. K., Yoo, B. (2015) Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod. Rheumatol. 25, 194–198. <https://doi.org/10.3109/14397595.2014.931908>
8. Laco, J., Podhola, M., Kamaradova, K., Novak, I., Dobes, D., Brodak, M., Hacova, M., Ryska, A. (2013) Idiopathic vs. secondary retroperitoneal fibrosis: A clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease. Virchows Arch. 463, 721–730. <https://doi.org/10.1007/s00428-013-1480-7>
9. Maritati, F., Corradi, D., Versari, A., Casali, M., Urban, M. L., Buzio, C., Vaglio, A. (2012) Rituximab therapy for chronic periaortitis. Ann. Rheum. Dis. 71, 1262–1264. <https://doi.org/10.1136/annrheumdis-2011-201166>
10. Marzano, A., Trapani, A., Leone, N., Actis, G. C., Rizzetto, M. (2001) Treatment of idiopathic retroperitoneal fibrosis using cyclosporine. Ann. Rheum. Dis. 60, 427–428. <https://doi.org/10.1136/ard.60.4.427> <PubMed>
11. Pelkmans, L. G., Aarnoudse, A. J., Hendriksz, T. R., van Bommel, E. F. (2012) Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrol. Dial. Transplant. 27, 2819–2825. <https://doi.org/10.1093/ndt/gfr779>
12. Restrepo, C. S., Ocazionez, D., Suri, R., Vargas, D. (2011) Aortitis: Imaging spectrum of the infectious and inflammatory conditions of the aorta. Radiographics 31, 435–441. <https://doi.org/10.1148/rg.312105069>
13. Scheel, P. J., Feeley, N. Jr., Sozio, S. M. (2011) Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann. Intern. Med. 154, 31–36. <https://doi.org/10.7326/0003-4819-154-1-201101040-00005>
14. Schmidt, W. A. (2013) Imaging vasculitis. Best Pract. Res. Clin. Rheumatol. 27, 107–118. <https://doi.org/10.1016/j.berh.2013.01.001>
15. Takahashi, H., Yamamoto, M., Suzuki, C., Naishiro, Y., Shinomura, Y., Imai, K. (2010) The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun. Rev. 9, 591–594. <https://doi.org/10.1016/j.autrev.2010.05.003>
16. Vaglio, A., Salvarani, C., Buzio, C. (2006) Retroperitoneal fibrosis. Lancet 367, 241–251. <https://doi.org/10.1016/S0140-6736(06)68035-5>
17. Vaglio, A., Catanoso, M. G., Spaggiari, L., Magnani, L., Pipitone, N., Macchioni, P., Pulsatelli, L., Nicastro, M., Becchi, G., Corradi, D., Versari, A., Boiardi, L., Salvarani, C. (2013) Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum. 65, 2469–2475. <https://doi.org/10.1002/art.38032>
18. van Bommel, E. F., Jansen, I., Hendriksz, T. R., Aarnoudse, A. L. (2009) Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 88, 193–201. <https://doi.org/10.1097/MD.0b013e3181afc420>
19. Zen, Y., Onodera, M., Inoue, D., Kitao, A., Matsui, O., Nohara, T., Namiki, M., Kasashima, S., Kawashima, A., Matsumoto, Y., Katayanagi, K., Murata, T., Ishizawa, S., Hosaka, N., Kuriki, K., Nakanuma, Y. (2009) Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am. J. Surg. Pathol. 33, 1812–1819.
20. Zen, Y., Kasashima, S., Inoue, D. (2012) Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease. Semin. Diagn. Pathol. 29, 212–218. <https://doi.org/10.1053/j.semdp.2012.07.003>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive